Scroll to:
Use of DIABAX feed additive and a biogenic stimulant in calves during their rehabilitation after gastrointestinal infections
https://doi.org/10.29326/2304-196X-2024-13-2-189-195
Abstract
The results of the use of DIABAX feed additive alone and in combination with a biogenic stimulant for the correction of biochemical, hematological blood parameters in young cattle after gastrointestinal infections taking into account the disease and survival rates, as well as their performance indicators are presented. Three groups of calves at the age of less than 30 days old, two test groups and one control group, were formed for analogous pairs-based trial. Calves of control group were subcutaneously injected with saline solution at a dose of 8 mL on day 1, 5, 10 of the trial; calves of test group 1 (О-1) were fed with DIABAX feed additive with milk at a dose of 3.0 mL once a day; calves of test group 2 (О-2) were intramuscularly injected with the biogenic stimulant at a dose of 0.5 mL/10 kg of body weight on day 1, 5, 10 of the trial and also received DIABAX at a dose of 3.0 mL once a day during 15 days. The tests showed that co-administration of the biogenic stimulant and DIABAX feed additive (in О-2 group) contributed to 100% survival rate in calves, as well as significant increase in calcium and magnesium levels in animal sera by 14.5–23.8% and 61.2–79.5%, respectively, as compared with the initial levels and the levels in control group; increase in albumin and α-globulin protein fraction concentrations by 10.1% and 43.2% (p ≤ 0.05), respectively, albumin/globulin ratio – by 17.5%, color index – by 1.1%, increase in the total immunoglobulin G amount by 2.7 times as compared to the initial values. Daily administration of DIABAX feed additive to calves of О-1 group for 15 days reduced recurrent disease rate in the calves by 14.4%, resulted in significant increase in calcium and magnesium levels in sera by 10.1% and 75.0% (p ≤ 0.05), respectively, as well increase in immunoglobulin G level by 2.3 times, erythrocyte level – by 3.8%, hemoglobin level – by 8.0%, leukocyte level – by 21.8%, albumin/globulin ratio – by 35.1% in sera as compared to initial values.
Keywords
For citations:
Shanshin N.V. Use of DIABAX feed additive and a biogenic stimulant in calves during their rehabilitation after gastrointestinal infections. Veterinary Science Today. 2024;13(2):189-195. https://doi.org/10.29326/2304-196X-2024-13-2-189-195
INTRODUCTION
Livestock survivability and performance improvement is one of the important challenges facing the Russian Federation agro-industrial complex [1][2]. Calf rearing are challenging since the newborns’ bodies are poorly adapted to adverse environmental conditions due to the morphofunctional immaturity of immune system and gastrointestinal tract during their first days of life [3]. This, in turn, results in the various gastrointestinal diseases in calves and their deaths [4][5][6], as well as the disease recurrence [7][8].
Therewith, complex rehabilitation procedures including use of various biological stimulants enabling vital component deficiency filling and contributing to the metabolic normalization and full-calf body resistance enhancement are required to maintain the metabolic status and homeostasis of the calves during their recovery [9][10][11][12][13].
The mechanism of biogenic stimulant action includes changes in activity of some enzymes due to the biogenic stimulant attachment to the enzyme protein. Changes in the enzyme activity results in endocrine restructuring, an increase in tropic hormones secreted by pituitary gland that stimulate adrenal gland, thyroid and pancreas functions, etc. They have a favorable impact on trophic function of the nervous system, enhance thyroid tissue and adrenal gland functions, stimulate corticosteroid hormone secretion and pancreatic gland function, regulate gastrointestinal tract secretory and motor functions, gas and phosphorus metabolism, intermediary metabolism, reticuloendothelial system and regenerative processes, improve body state, appetite, assimilation processes that contribute to higher weight gains [14][15].
The study was aimed at testing of DIABAX feed additive and a biogenic stimulant for their effectiveness for correction of biochemical, hematological blood parameters in young cattle after gastrointestinal infections.
Test tasks:
- To test used feed additive and biogenic stimulant for their effects on morphological and biochemical blood parameters in calves during their rehabilitation after gastrointestinal infections.
- To test the feed additive and biogenic stimulant for their effects on disease rate and survival rate in calves, calf performance during their rehabilitation period.
MATERIALS AND METHODS
Bacteriological tests of calf feces were carried out for the purpose of diagnosis. Isolated microorganisms were tested for their sensitivity to antimicrobials with disk diffusion test [16].
A pilot batch of biogenic stimulant was prepared from raw materials (slaughter waste, category II offal) kept in a refrigerator at temperature of +2 up to +4 °С for 5–7 days, ground and then mixed with an extraction agent at the Department of the All-Russian Institute of Antler Reindeer Breeding, Altai Scientific Center for Agrobiotechnologies. The ultrasonic-assisted extraction was carried out; the final product was filtered, packed, and sterilized in an autoclave [17]. Administration of the biogenic stimulant enhances metabolism, body’s resistance and stimulates body’s functions.
DIABAX, a new feed additive, developed by the GK KONSTANTA (Saransk) [18] is a viscous fluid of light-brown color with slight odor, has a bactericidal, bacteriostatic effect on a wide range of microorganisms and pathogenic fungi owing to potassium iodide and electrostatically charged polyelectrolyte polydimethyldiallylammonium chloride contained in it. DIABAX feed additive is highly soluble in water, does not change medium pH level, remains active in acidic and alkaline media, as well as in protein and fatty media. The principle feature of the additive is inhibition of pathogenic microflora based on its physical, but not chemical effect, while its components has no adverse effect on normal gastrointestinal cells of animals. Polyelectrolyte has an electrostatic charge opposite to the charge of cells of pathogenic bacteria, fungi and other microorganisms. When Diabax feed additive interacts with the pathogen surface. This interaction leads to microorganism cell membrane is encapsulation that slows down and then completely inhibits microorganism breathing, nutrition and reproducibility.
For the trial aimed at testing of the restorative treatment for its effectiveness in calves during their rehabilitation after gastrointestinal infections, 3 groups of 10–30 day-old calves were formed according to the analogous pairs principle: two test (T-1, T-2) groups and one control (C) group. Tested products were administered to the calves according to the scheme presented in Table 1.
Table 1
Scheme of tested product administration to calves of test and control groups
Group of animals |
Number of animals |
Administered product |
C |
6 |
Saline solution administered at a dose of 8.0 mL subcutaneously on day 1, 5, 10 of the trial |
T-1 |
7 |
DIABAX administered daily at a dose of 3.0 mL once a day for 15 days |
T-2 |
5 |
Biogenic stimulant administered intramuscularly at a dose of 0.5 mL/10 kg of body weight |
All procedures involving animals were carried out in accordance with ethical standards laid down by European Convention ETS No. 123.
The feed additive and biogenic stimulant were tested for their effectiveness based on the following: morphological tests of blood (total erythrocyte counts, total leukocyte counts, hemoglobin level) using conventional methods [19]; biochemical tests of sera: refractometric determination (IRF-22, Russia) of serum total protein, nephelometric determination of protein fractions [20]; ELISA determination of total immunoglobulin G using appropriate ELISA test-kit; determination of serum mineral content by unified method using Vital Diagnostics SPb kits (Russia) and Stat Fax® 1904+ biochemical photometer (Awareness Technology, Inc., USA); bacteriological tests of biological material samples in accordance with the Methodological Guidelines1, 2.
Blood samples were collected before the trial and 10 days after the trial completion. Mean values was assessed for their reliability of using Student’s – Fisher’s test.
RESULTS AND DISCUSSION
The gastrointestinal disease incidence in calves kept on the farm periodically rises due to violation of zootechnical and veterinary rules for animal keeping, feeding and handling during mass calving. The etiological causes are: diseased animals, convalescent animals, dams – pathogenic microorganism strain carriers, infected environment. The following bacteria were detected in feces from diseased calves subjected to bacteriological tests: Salmonella Dublin, Mannheimia haemolytica, all isolated bacteria strains were pathogenic for white mice. Levofloxacin, marfloxin, enrofloxacin, norfloxacin, ofloxacin, polymyxin, kanamycin were found to be effective antimicrobials. At the final stage of the trial, no pathogenic microorganism strains were detected during the bacteriological tests of fecal samples from calves of test and control groups.
Tests of the blood samples collected before the trial aimed at testing DIABAX feed additive and biogenic stimulant for their effectiveness for correction of biochemical, hematological blood parameters in calves during their rehabilitation after gastrointestinal infections showed decrease in phosphorous level by 19.1%, calcium level by 9.2%, magnesium level by 46.3% as compared with the physiological norm and simultaneous increase in zinc level by 3.5% as compared to the physiological norm (Table 2).
Table 2
Micro- and macroelement levels in sera from calves used for the trial
Mean value for group |
P, mmol/L |
Са, mmol/L |
Mg, mmol/L |
К, mmol/L |
Zn, μmol/L |
Normal range |
1.78–2.42 |
2.50–3.00 |
0.82–1.23 |
4.10–4.86 |
15.40–23.00 |
I |
1.44 ± 0.17 |
2.27 ± 0.442 |
0.44 ± 0.14 |
4.90 ± 1.99 |
23.80 ± 1.56 |
C |
2.10 ± 0.161 |
2.10 ± 0.111 |
0.49 ± 0.09 |
4.60 ± 0.38 |
23.60 ± 1.08 |
± to/from I, % |
+ 45.80 |
– 7.50 |
+ 11.40 |
– 6.10 |
– 0.80 |
T-1 |
1.78 ± 0.121 |
2.50 ± 0.120* |
0.77 ± 0.02* |
4.70 ± 0.18 |
22.50 ± 1.52 |
± to/from I, % |
+ 23.60 |
+ 10.10 |
+ 75.00 |
– 4.10 |
– 5.50 |
± to/from C, % |
– 15.20 |
+ 19.00 |
+ 57.10 |
+ 2.20 |
– 4.70 |
T-2 |
1.79 ± 0.152 |
2.60 ± 0.110* |
0.79 ± 0.03* |
4.8 ± 0.67 |
22.3 ± 1.27 |
± to/from I, % |
+ 24.30 |
+ 14.50 |
+ 79.50 |
– 2.00 |
– 6.30 |
± to/from C, % |
– 14.80 |
+ 23.80 |
+ 61.20 |
+ 4.30 |
– 5.50 |
* p < 0.05; I – initial values, C – values in control group.
Calves of both test groups demonstrated normalization of serum phosphorus level, a significant increase in serum calcium level by 19.0% in the T-1 group and by 23.8% in the T-2 group (p < 0.05) as compared to that ones in sera from control group calves, in serum magnesium level – by 57.1% in T-1 group and by 61.2% in T-2 group (p < 0.05), serum potassium level – by 2.2% in T-1 group and by 4.3% in T-2 group 10 days after completion of tested feed additive and biogenic stimulant administration. There was a positive dynamics of zinc level decrease by 0.8% in sera from control group calves, by 5.5% in sera from T-1 test group calves, by 6.3% in sera from T-2 test group calves as compared to initial values during the rehabilitation period.
Biochemical tests of calf sera collected before the trial showed slight decrease in albumin protein fraction by 4.7%, and α-globulin protein fraction by 23.3%. Decrease in albumin-globulin ratio by 31.3% is indicative of imbalance between the protein fractions, 14.0% decrease in the amount of immunoglobulins G mainly responsible for humoral immunity is indicative of body protective function suppression in animals used for the trial (Table 3).
Table 3
Concentrations of total protein, protein fractions in sera from the calves used for the trial
Group of animals |
Total protein, g/L |
Albumins, % |
Globulins, % |
A/G ratio, units |
Immunoglobulin G, mg/mL |
||
α |
β |
γ |
|||||
Normal range |
56.9–65.0 |
38–50 |
12–20 |
10–16 |
25–40 |
0.83–1.19 |
> 10 |
I |
66.4 ± 8.42 |
36.2 ± 8.91 |
9.2 ± 4.34 |
15.8 ± 7.57 |
39.0 ± 5.09 |
0.57 ± 0.22 |
8.6 ± 3.39 |
C |
60.0 ± 1.71 |
38.5 ± 1.21 |
12.5 ± 1.53 |
21.2 ± 1.72 |
27.8 ± 1.92 |
0.63 ± 0.114 |
14.8 ± 3.45 |
± to/from I, % |
– 9.6 |
+ 6.4 |
+ 35.9 |
+ 34.2 |
– 28.7 |
+ 10.5 |
+ 72.1 |
T-1 |
56.9 ± 2.88 |
43.5 ± 0.82* |
12.7 ± 0.76 |
13.6 ± 1.15* |
30.2 ± 1.28 |
0.77 ± 0.010 |
19.7 ± 1.78 |
± to/from I, % |
– 14.3 |
+ 20.2 |
+ 38.0 |
– 13.9 |
– 22.6 |
+ 35.1 |
2.3-fold increase |
± to/from C, % |
– 5.2 |
+ 13.0 |
+ 1.6 |
– 35.8 |
+ 8.6 |
+ 22.2 |
+ 33.1 |
T-2 |
60.1 ± 3.66 |
42.4 ± 1.06* |
17.9 ± 1.27* |
15.0 ± 1.18* |
24.7 ± 2.05 |
0.74 ± 0.052 |
23.0 ± 2.16 |
± to/from I, % |
– 9.5 |
+ 17.1 |
+ 94.6 |
– 5.1 |
– 36.7 |
+ 29.8 |
2.7-fold increase |
± to/from C, % |
0 |
+ 10.1 |
+ 43.2 |
– 29.2 |
– 11.2 |
+ 17.5 |
+ 55.4 |
* p < 0,05; А/G – albumin/globulin ratio, I – initial values, C – values in control group.
At the final stage of the trial, albumin and α-globulin protein fractions in the calf sera were found to normalize to the physiological norm with a significant increase (p ≤ 0.05) in albumin levels in T-1 and T-2 groups and α-globulin fraction in T-2 group. In calves of control group, serum β-globulin level increased by 34.2% as compared to the initial values and significantly differed (p ≤ 0.05) from the test group values. Albumin-globulin ratio in animals of control group and test groups increased by 10.5% and 29.8–35.1% during the period of rehabilitation of the calves after gastrointestinal infections.
Immunoglobulin G amount reached its physiological norm in sera from test group calves. Immunoglobulin G amount increased by 72.1% in calves of control group and by 2.3–2.7 times in calves of test groups as compared to the initial values.
Analysis of hematological blood parameters in calves at the beginning and at the end of the trial showed no significant differences between the control and test groups. There was a positive trend towards an increase in the tested blood parameters within the physiological norm at the final stage of rehabilitation of calves in test groups as compared to the initial values and blood parameters of calves in control group (Table 4).
Table 4
Hematological blood parameters in the calves used for the trial
Group of animals |
Erythrocytes, 10¹²/L |
Hemoglobin, g/L |
Leukocytes, 10⁹/L |
Color index, units |
Normal range |
7.40–8.60 |
99.00–128.00 |
4.50–12.00 |
0.70–1.10 |
I |
8.00 ± 1.36 |
98.00 ± 17.40 |
5.50 ± 1.16 |
0.87 ± 0.14 |
C |
8.20 ± 0.33 |
104.00 ± 4.67 |
6.00 ± 0.50 |
0.90 ± 0.04 |
± to/from I, % |
+ 2.5 |
+ 6.1 |
+ 9.1 |
+ 3.4 |
T-1 |
8.30 ± 0.60 |
105.80 ± 4.33 |
6.70 ± 0.63 |
0.90 ± 0.04 |
± to/from I, % |
+ 3.8 |
+ 8.0 |
+ 21.8 |
+ 3.4 |
± to/from C, % |
+ 1.2 |
+ 1.7 |
+ 11.7 |
0 |
T-2 |
8.40 ± 0.42 |
108.00 ± 4.84 |
6.90 ± 0.59 |
0.91 ± 0.06 |
± to/from I, % |
+ 5.0 |
+ 10.2 |
+ 25.5 |
+ 4.6 |
± to/from C, % |
+ 2.4 |
+ 3.8 |
+ 15.0 |
+ 1.1 |
I – initial values, C – values in control group.
In test groups all calves survived (100% survival rate) during rehabilitation period when the tested feed additive and biogenic stimulant were administered to the calves and then during 60-day clinical observation period (Table 5). Disease rate was 66,7% in control group calves that was higher by 14.4 and 40.0% than that one in T-1 and T-2 groups, respectively.
Table 5
Disease and survival rates in the calves used for the trial
Group of animals |
Number of animals |
Diseased |
Died |
Decrease in proportion of diseased animals in test group as compared to control group, % |
||
Number of animals |
% |
Number of animals |
% |
|||
C |
6 |
4 |
66.7 |
1 |
16.7 |
– |
T-1 |
7 |
4 |
57.1 |
– |
– |
14.4 |
T-2 |
5 |
2 |
40.0 |
– |
– |
40.0 |
Increase in average daily weight gains by 33.5% in T-1 group and by 27.9% in T-2 group as compared to daily weight gains in control group was recorded during the first control weighing of the calves used for the trail (30 days after the trial start). During the second control weighing of the calves preformed 60 days after the trial start, 55.5–67.7% increase was recorded. Average daily weigh gain in T-1 group calves and in T-2 group calves was by 10.6% and 4.3% higher than that one in control group calves during the whole calf raising period (Table 6).
Table 6
Average body weight of the calves by group
Group of animals |
Birth weight |
Control weighing, kg |
Observation period, days |
Average daily weight gain, g |
|||
at the beginning of the trial |
30 days after the trial start |
60 days after the trial start |
during 30/60 days of observation |
during the whole raising period |
|||
С |
39.00 ± 0.61 |
89.20 ± 10.34 |
105.30 ± 5.59 |
126.50 ± 12.05 |
113 |
537/622 |
774 ± 87.6 |
T-1 |
38.60 ± 0.46 |
85.00 ± 5.23 |
106.50 ± 8.89 |
143.00 ± 8.78 |
122 |
717/967 |
856 ± 67.7 |
T-2 |
37.20 ± 0.27 |
73.80 ± 3.84 |
94.40 ± 8.40 |
136.40 ± 8.59 |
123 |
687/1,043 |
807 ± 70.0 |
The test results show that administration of the biogenic stimulant of animal origin by injections and DIABAX feed additive (in T-2 group) with milk contribute to 100% survival rate in calves, significant increase in calcium and magnesium levels in the animal sera by 14.5–23.8% and 61.2–79.5%, respectively, as compared to the initial levels and levels in control group, an increase in albumin and α-globulin protein fractions by 10.1 and 43.2% (p ≤ 0.05), respectively, as compared to that ones in control group, increase in albumin/globulin ratio by 17.5%, color index – by 1.1% as compared to that ones in control group, the total immunoglobulin G amount was 2.7 times higher than the initial value. Daily administration of DIABAX feed additive to calves of T-1 group for 15 days reduced recurrent disease rate in the calves by 14.4%, resulted in significant increase in serum calcium and magnesium levels by 10.1 and 75.0% (p ≤ 0.05), respectively, as well as in increase in immunoglobulin G level by 2.3 times, erythrocyte level – by 3.8%, hemoglobin level – by 8.0%, leukocyte level – by 21.8%, albumin/globulin ratio – by 35.1% as compared to the initial values.
CONCLUSIONS
- Daily administration of DIABAX feed additive to calves for 15 days contributed to significant increase in serum calcium, magnesium, albumin, β-globulin levels (p ≤ 0.05) in T-1 group calves, decrease in number of diseased animals by 14.4% and 100% survivability in T-2 group calves as compared to control group calves, increase in average daily weigh gain by 55.5% as compared to that ones in control group calves during 60-day observation period.
- Combination of the biogenic stimulant injections to calves on day 1, 5, 10 of the trial and adding DIABAX feed additive to the calf diet for 15 consecutive days contributed to a significant increase in calcium, magnesium, albumin levels, α-, β-globulin protein fractions (p ≤ 0.05), decrease in disease rates by 40.0 and 29.9%, as well as an increase in average daily weight gain by 67.7 and 7.9% as compared to that ones in control and T-1 groups, respectively, during 60-day observation period with 100.0% survival rate in T-2 test group calves.
Contribution: Shanshin N. V. – collection of biological materials and preparation of pilot biogenic stimulant batch, collection of blood samples from the animals, morphological and biochemical tests, analysis of the obtained data, systematization and statistical processing, preparation of the paper for publication.
Вклад автора: Шаньшин Н. В. – лично автором произведен отбор биоматериала и изготовлена опытная партия биогенного препарата, осуществлен забор крови у животных, проведены морфо-биохимические исследования, анализ, систематизация и статистическая обработка полученных данных, подготовка статьи к публикации.
1. MG 4.2.2723-10 Laboratory diagnosis of salmonellosis, Salmonella detection in food products and environmental samples: methodical guidelines (approved by Chief Medical Officer of the Russian Federation on 13 August 2010). https://docs.cntd.ru/document/1200083950?ysclid=lvgmjzwhv062935169
2. Methodical Guidelines for laboratory diagnosis of animal and avian pasteurellosis: approved by the Veterinary Department of the Ministry of Agriculture of the USSR No. 22-7/82 on 20 August 1992. https://docs.cntd.ru/document/456071306?ysclid=lvgn11uqfc818248150
References
1. Chernitskiy A. E., Shabunin S. V. Prophylaxis of respiratory diseases in neonatal calves with low viability. Veterinariya. 2017; (9): 10–16. https://elibrary.ru/zmmitx (in Russ.)
2. Gerceva K. A., Nikulova L. V., Kiseleva E. V. An effective strategy for the treatment of toxic dyspepsia in calves. International Journal of Veterinary Medicine. 2023; (1): 307–317. https://doi.org/10.52419/issn2072-2419.2023.1.307 (in Russ.)
3. Vakhrusheva T. I. Analiz zabolevaemosti molodnyaka krupnogo skota vnutrennimi nezaraznymi patologiyami v AO PZ «Krasnoturanskii» Krasnoyarskogo kraya = Analysis of the occurrence of non-contagious internal organ pathologies in calves on the AO PZ“Krasnoturansky”breeding farm in the Krasnoyarsk Krai. Rol’ agrarnoi nauki v ustoichivom razvitii sel’skikh territorii: sbornik IV Vserossiiskoi (natsional’noi) nauchnoi konferentsii (Novosibirsk, 20 dekabrya 2019 g.) = The role of agricultural science in the sustainable development of rural areas: proceedings of the IV All-Russia (National) Scientific Conference (Novosibirsk, 20 December 2019). Novosibirsk: Its NSAU“Zolotoi Kolos”; 2019; 194–197. https://elibrary.ru/quvwdb (in Russ.)
4. Vakhrusheva T. I. Dispepsiya telyat – opyt lecheniya i profilaktiki v usloviyakh khozyaistv Krasnoyarskogo kraya = Calf dyspepsia – experience of treatment and prevention on farms in the Krasnoyarsk Krai. Nauchnoe obespechenie zhivotnovodstva Sibiri: materialy IV Mezhdunarodnoi nauchnoi prakticheskoi konferentsii (Krasnoyarsk, 14–15 maya 2020 g.) = Scientific support of Siberian animal farm industry: proceedings of the IV International Scientific and Practical Conference (Krasnoyarsk, 14–15 May 2020). Krasnoyarsk: Krasnoyarsk Scientific-Research Institute of Animal Husbandry – Division of Federal Research Center “Krasnoyarsk Scientific Center of the Siberian Branch of the RAS”; 2020; 417–421. https://elibrary.ru/gniozf (in Russ.)
5. Novikova T. V., Mekhanikova M. V., Bilkov V. A. The reaction of hematological parameters of calves to transferred dyspepsia. Journal of Biochemical Technology. 2023; 14 (2): 1–5. https://doi.org/10.51847/dSUMJIfip2
6. Köse S., Şehu A. Effects of a commercial feed additive used for prophylactic purposes on health and blood parameters in neonatal calves. Tierärztliche Praxis Ausgabe G: Grosstiere/Nutztiere. 2024; 52 (1): 16–24. https://doi.org/10.1055/a-2220-1645
7. Shadskaya A. V. The effective treatment setting for calves with dyspepsia under production conditions. Bulletin of Agrarian Science. 2022; (5): 65–69. https://elibrary.ru/ftaywv (in Russ.)
8. Poryvaeva A. P., Krasnoperov A. S., Tomskikh O. G., Lysova Ya. Yu. Model of estimation of risk of development of complications when dyspepsia in calves. Agrarian Bulletin of the Urals. 2019; (1): 31–37. https://doi.org/10.32417/article_5ca4e6ff8e24c2.87308778 (in Russ.)
9. Burova O., Blokhin A., Isaev V. Prevention of gastrointestinal diseases of calves with application of biologically active substances. Agricultural Science Euro-North-East. 2014; (3): 36–39. https://elibrary.ru/scjkqt (in Russ.)
10. Smolentsev S. Yu. Imroving the preseration of calves by using immunostimulants together with a mineral fodder additive. Scientific Life. 2017; (2): 49–55. https://elibrary.ru/yhfazn (in Russ.)
11. Sanin A. V., Narovlyanskiy A. N., Pronin A. V., Kozhevnikova T. N. Increase of the innate immunity and hemostasis correction in calves using medications with immunomodulating and biostimulating activity. Russian Veterinary Journal. 2020; (2): 31–38. https://doi.org/10.32416/2500-4379-2020-2-31-38 (in Russ.)
12. Bazekin G. V. Immunobiochemical and clinical-morphological assessment of the glycyrrhizic acid and nucleostim effect on animals: Author’s abstract of thesis for degree of Dr. Sci. (Veterinary Medicine). Ufa; 2022. 363 p. (in Russ.)
13. Sanin A. V., Savoyskaya S. L., Kozhevnikova T. N., Sanina V. Yu., Sosnovskaya O. Yu. Safety, growth, development and non-specific resistance increasing of calves with help of modern immunomodulatory preparations. Veterinaria Kubani. 2019; (2): 11–14. https://doi.org/10.33861/2071-8020-2019-2-11-14 (in Russ.)
14. Mashkovsky M. D. State Pharmacopeia of the Russian Federation. 16th edition, revised, corrected and supplemented. Moscow: Novaya Volna; 2012. 1216 p. (in Russ.)
15. Daricheva N. N., Ermolaev V. A. Tissue therapy in veterinary medicine: monograph. Ulyanovsk: Ulyanovsk State Agricultural Academy; 2011. 168 p. (in Russ.)
16. Gosmanov R. G., Ravilov R. Kh., Galiullin A. K., Nurgaliyev F. M., Idrisov G. G. Laboratory diagnosis of infectious diseases: study guide. Saint Petersburg: Lan’; 2022. 196 p. (in Russ.)
17. Shanshin N. V., Evseeva T. P. Biogenic preparations production method. Patent No. 2698707 Russian Federation. Int. Cl. A61K 35/12, B01D 11/02, B01J 19/10. FGBNU FANTSA. No. 2019113424. Date of filing: 29.04.2019. Date of publication: 29.08.2019. Bull. No. 25. (in Russ.)
18. DIABAXTM feed additive; DIABAX: declaration of conformity РОСС RU Д-RU.РА02.В.14405/21. https://reestrinform.ru/reestr-declaratcii-sootvetstviia/reg_number-РОСС_RU_Д-RU.РА02.В.14405--21.html
19. Kudryavtsev A. A., Kudryavtseva L. A. Clinical hematology of animals. Moscow: Kolos; 1974. 399 p. (in Russ.)
20. Methods for veterinary clinical laboratory diagnosis: guide. Ed. by I. P. Kondrakhin. Moscow: KolosS; 2004. 520 p. (in Russ.)
About the Author
N. V. ShanshinRussian Federation
Nikolay V. Shanshin, Cand. Sci. (Veterinary Medicine), Leading Researcher, Head of Laboratory of Animal Breeding and Diseases
160 Shevchenko str., Barnaul 656031, Altai Krai
Review
For citations:
Shanshin N.V. Use of DIABAX feed additive and a biogenic stimulant in calves during their rehabilitation after gastrointestinal infections. Veterinary Science Today. 2024;13(2):189-195. https://doi.org/10.29326/2304-196X-2024-13-2-189-195